SCHEMBL18582829

SCHEMBL18582829

CC(Oc1cc(Br)ccc1[N+](=O)[O-])c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.42
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
SLC6A4 P31645 4/20 0.38
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
HTR6 P50406 2/20 0.38
RORC P51449 2/20 0.38
SLC6A2 P23975 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
RECQL P46063 1/20 0.36
GBA1 P04062 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 2/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18582827 1.00 LRRK2 (0.42) LRRK2ALDH1A1TDP1CRHBPCRHR2
SCHEMBL31402301 0.86 MAPK1 (0.40) ALDH1A1SLC6A4HTR2CHTR2BHTR6
SCHEMBL25889282 0.86 MAPK1 (0.40) ALDH1A1SLC6A4HTR2CHTR2BHTR6
SCHEMBL25298519 0.86 TDP1 (0.40) ALDH1A1TDP1SLC6A4L3MBTL1MAPT
SCHEMBL29024322 0.86 MAPK1 (0.40) ALDH1A1SLC6A4HTR2CHTR2BHTR6
SCHEMBL25256796 0.86 TDP1 (0.40) ALDH1A1TDP1SLC6A4L3MBTL1MAPT
SCHEMBL11292180 0.82 ALDH1A1 (0.56) ALDH1A1TDP1CRHBPCRHR2SLC6A4
SCHEMBL29509060 0.82 PDK1 (0.47) ALDH1A1TDP1L3MBTL1MAPTNPC1
SCHEMBL7481571 0.82 PDK1 (0.47) ALDH1A1TDP1L3MBTL1MAPTNPC1
SCHEMBL31757210 0.81 ALDH1A1 (0.42) ALDH1A1TDP1L3MBTL1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790207-B2 Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods IVACHTCHENKO ALEXANDRE VASILIEVICH (US) 2017-10-17 US disclosed
US-20170066746-A1 Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods IVACHTCHENKO ALEXANDRE VASILIEVICH (US) 2017-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066746-A1 Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods POLR2A, GTF3C1, SSU72 LRRK2 649/4885ALDH1A1 3333/4885TDP1 1680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.